EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›WORX

WORX

SCWorx Corp.

Next earnings Aug 12, 2026

Avoid
$0.41
▲ +0.02%
$0.41▼ -93.51%
over 1Y
L $0.26EODHDH $6.96
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+29.4%
1M+56.8%
3M-77.6%
YTD-86.4%
1Y-93.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)

Conservative balance sheet (liabilities/equity 0.10x); but revenue declined -3.7% YoY.

Revenue (FY2025) $2.88M · FY2025

SCWorx Corp. shows $2.88M in FY2025 revenue (-3.7% YoY), a -154.4% net margin, and -62.1% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.63M$4.04M$3.80M$2.99M$2.88M
Gross profit—$1.41M$1.27M$746K$920K
Operating income-$3.81M-$2.12M-$1.45M-$1.26M-$959K
Net income-$3.81M-$1.85M-$3.98M-$1.14M-$4.44M
Diluted EPS-$0.36-$2.32-$3.86-$0.78-$0.61
Net margin-82.3%-45.7%-104.6%-38.0%-154.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$4.98M
EV / EBITDA—
EV / Sales1.7
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-67.1%
FCF yield-25.0%

Quality & risk

ROIC (est.)-10.6%
Free cash flow-$1.66M
Total debt—
Net cash$1.64M
Altman Z-Score-0.78 distress
Piotroski F-Score3/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+659.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-04-10). Worth a closer look.
  1. 8-K Other event2026-06-23
  2. DEF 14A Proxy statement2026-06-12
  3. 10-Q Quarterly report2026-05-15
  4. 8-K Delisting notice2026-04-10
  5. 8-K Other event2026-04-07
  6. 10-K Annual report2026-03-31
  7. S-1 Securities registration2026-01-08
  8. 8-K Shareholder vote2025-12-10
  9. 10-Q Quarterly report2025-11-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-23open ↗DEFR14AFiling2026-06-16open ↗DEF 14APeriod ending 2026-07-222026-06-12open ↗PRE 14APeriod ending 2026-06-012026-06-01open ↗10-QPeriod ending 2026-03-312026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗8-KPeriod ending 2026-04-072026-04-10open ↗8-KPeriod ending 2026-04-072026-04-07open ↗10-KPeriod ending 2025-12-312026-03-31open ↗SCHEDULE 13G/AFiling2026-02-17open ↗EFFECTFiling2026-01-16open ↗S-1Filing2026-01-08open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueB
GrowthF
ProfitabilityF
Financial healthB-
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$2.88M
-3.7% YoY
Net margin
-154.4%
ROE
-62.1%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.88M-3.7%
Net income-$4.44M-291.1%
Gross profit$920K+23.3%
Operating income-$959K+23.9%
Diluted EPS-$0.61+21.8%
Cash & equivalents$1.64M+1441.8%
Total assets$7.90M+24.4%
Total liabilities$744K-59.9%
Stockholders' equity$7.15M+59.3%
Gross: 32.0%Op.: -33.3%L/E: 0.10x

Frequently asked

Is SCWorx Corp. (WORX) a buy?
WORX currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.10x); but revenue declined -3.7% YoY.
What is SCWorx Corp.'s quality score?
WORX scores 44.764705882352935/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001674227, latest 10-Q filed 2026-05-15) · EODHD · as of 6/26/2026, 4:31:16 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2024-05-15
Matozzo Vincent Michael
Director
Disposed (D)3.06K
2024-05-15
IRBY ALTON F III
Director
Disposed (D)6.67K
2024-05-15
IRBY ALTON F III
Director
Disposed (D)6.67K
2024-05-15
IRBY ALTON F III
Director
Disposed (D)6.67K
2024-05-15
Horowitz Steven Ross
Director
Disposed (D)2.78K
2024-05-15
Horowitz Steven Ross
Director
Disposed (D)6.00K
2024-05-15
Horowitz Steven Ross
Director
Disposed (D)7.33K
2023-04-11
IRBY ALTON F III
Director
Award120K
2023-04-11
Horowitz Steven Ross
Director
Award110K
2023-04-11
FERRARA JOHN C
Director
Award110K
2021-09-14
Kohler Christopher John
Chief Financial Officer
Award36.0K
2021-08-11
Horowitz Steven Ross
Director
Award41.7K

Recent news

market news →
BC-Most Active StocksBullish
finance.yahoo.com· 2026-02-12
BC-Most Active StocksBullish
finance.yahoo.com· 2026-01-23
SCWorx Announces New Academic Hospital CustomerBullish
globenewswire.com· 2025-12-17
BC-Most Active StocksBullish
finance.yahoo.com· 2025-11-06
SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price RequirementBullish
finance.yahoo.com· 2025-10-14
SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price RequirementBullish
globenewswire.com· 2025-10-14

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score45 vs 67
Revenue growth-3.7% vs 7.1%
Net margin-154.4% vs 10.5%
Return on equity-62.1% vs 12.3%
P/E— vs 25.5